AKT1 and graft versus host disease: Defibrotide has inhibited PI3K/AKT activation in endothelial cells derived from human umbilical vein and an immortalized human microvascular cell line induced by HCT patients’ sera [33] and in microvascular endothelial cells with AKT activation stimulated by exposure to GvHD patient serum [34].